{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:41:37Z","timestamp":1771558897327,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11604-019-00893-5","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T23:13:34Z","timestamp":1572045214000},"page":"826-831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9157-643X","authenticated-orcid":false,"given":"Rika","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yoshizako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Katsube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Kitagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"893_CR1","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0140-6736(88)90596-X","volume":"332","author":"U Schaad","year":"1988","unstructured":"Schaad U, Wedgwood-Krucko J, Tschaeppeler H. Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet. 1988;332:1411\u20133.","journal-title":"Lancet"},{"key":"893_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/jac\/25.4.689","volume":"25","author":"A Cometta","year":"1990","unstructured":"Cometta A, Gallot-Lavall\u00e9e-Villars S, Iten A, et al. Incidence of gallbladder lithiasis after ceftriaxone treatment. J Antimicrob Chemother. 1990;25:689\u201395.","journal-title":"J Antimicrob Chemother"},{"key":"893_CR3","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1128\/AAC.34.6.1146","volume":"34","author":"KL Heim-Duthoy","year":"1990","unstructured":"Heim-Duthoy KL, Caperton EM, Pollock R, et al. Apparent biliary pseudolithiasis during ceftriaxone therapy. Antimicrob Agents Chemother. 1990;34:1146\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"893_CR4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2214\/ajr.157.5.1927791","volume":"157","author":"EG Kassner","year":"1991","unstructured":"Kassner EG. Drug-related complications in infants and children: imaging features. AJR Am J Roentgenol. 1991;157:1039\u201349.","journal-title":"AJR Am J Roentgenol"},{"key":"893_CR5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.7326\/0003-4819-115-9-712","volume":"115","author":"AJ Lopez","year":"1991","unstructured":"Lopez AJ, O'Keefe P, Morrissey M, et al. Ceftriaxone-induced cholelithiasis. Ann Intern Med. 1991;115:712\u20134.","journal-title":"Ann Intern Med"},{"key":"893_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2214\/ajr.159.2.1632349","volume":"159","author":"W Kirejczyk","year":"1992","unstructured":"Kirejczyk W, Crowe H, Mackay I, et al. Disappearing \u201cgallstones\u201d: biliary pseudolithiasis complicating ceftriaxone therapy. AJR Am J Roentgenol. 1992;159:329\u201330.","journal-title":"AJR Am J Roentgenol"},{"key":"893_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.7326\/0003-4819-130-4-199902160-00016","volume":"130","author":"CW Ko","year":"1999","unstructured":"Ko CW, Sekijima JH, Lee SP. Biliary sludge. Ann Intern Med. 1999;130:301\u201311.","journal-title":"Ann Intern Med"},{"key":"893_CR8","first-page":"31","volume":"18","author":"M Alehossein","year":"2008","unstructured":"Alehossein M, Sotoudeh K, Nasoohi S, et al. Ceftriaxone induced biliary pseudolithiasis in children: report of 14 cases. Iran J Pediatr. 2008;18:31\u20137.","journal-title":"Iran J Pediatr"},{"key":"893_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/(SICI)1097-0096(200005)28:4<166::AID-JCU2>3.0.CO;2-G","volume":"28","author":"A Palanduz","year":"2000","unstructured":"Palanduz A, Yal\u00e7\u0131n I, Tongu\u00e7 E, et al. Sonographic assessment of ceftriaxone associated biliary pseudolithiasis in children. J Clin Ultrasound. 2000;28:166\u20138.","journal-title":"J Clin Ultrasound"},{"key":"893_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1055\/s-2007-1025261","volume":"205","author":"M Riccabona","year":"1993","unstructured":"Riccabona M, Kerbl R, Schwinger W, et al. Ceftriaxone-induced cholelithiasis\u2014a harmless side-effect? Klin Padiatr. 1993;205:421\u20133.","journal-title":"Klin Padiatr"},{"key":"893_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.idcr.2017.06.007","volume":"9","author":"A Shuichi","year":"2017","unstructured":"Shuichi A. A case of ceftriaxone-associated biliary pseudolithiasis in an elderly patient with renal dysfunction. IDCases [Internet]. 2017;9:62\u20134.","journal-title":"IDCases [Internet]"},{"issue":"5","key":"893_CR12","first-page":"161","volume":"2","author":"H Nakajima","year":"2014","unstructured":"Nakajima H, Ota S, Hirose T, et al. Ceftriaxone-associated cholelithiasis in adult patients with bacterial meningitis. J Infect Dis Ther [Internet]. 2014;2(5):161.","journal-title":"J Infect Dis Ther [Internet]"},{"key":"893_CR13","first-page":"258","volume":"51","author":"H Besim","year":"2016","unstructured":"Besim H, Arslan K. Ceftriaxone associated acute cholecystitis. Arch Balk Med Union. 2016;51:258\u201360.","journal-title":"Arch Balk Med Union"},{"key":"893_CR14","first-page":"462165","volume":"2015","author":"D Khurram","year":"2015","unstructured":"Khurram D, Shamban L, Kornas R, et al. Marked Direct hyperbilirubinemia due to ceftriaxone in an adult with sickle cell disease. Case Rep Gastrointest Med [Internet]. 2015;2015:462165.","journal-title":"Case Rep Gastrointest Med [Internet]."},{"key":"893_CR15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s00247-003-0963-0","volume":"33","author":"JS Prince","year":"2003","unstructured":"Prince JS, Senac MO. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child. Pediatr Radiol. 2003;33:648\u201351.","journal-title":"Pediatr Radiol"},{"key":"893_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1148\/radiology.162.2.3797654","volume":"162","author":"JA Barakos","year":"1987","unstructured":"Barakos JA, Ralls P, Lapin SA, et al. Cholelithiasis: evaluation with CT. Radiology. 1987;162:415\u20138.","journal-title":"Radiology"},{"key":"893_CR17","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/0016-5085(90)90486-K","volume":"99","author":"ML Shiffman","year":"1990","unstructured":"Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone-associated biliary sludge. Gastroenterology. 1990;99:1772\u20138.","journal-title":"Gastroenterology"},{"key":"893_CR18","first-page":"167","volume":"26","author":"J Brogard","year":"1988","unstructured":"Brogard J, Blickle J, Jehl F, et al. High biliary elimination of ceftriaxone in man. Int J Clin Pharmacol Ther Toxicol. 1988;26:167\u201372.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"893_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJM199001183220301","volume":"322","author":"UB Schaad","year":"1990","unstructured":"Schaad UB, Suter S, Gianella-Borradori A, et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med. 1990;322:141\u20137.","journal-title":"N Engl J Med"},{"key":"893_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00467-011-2038-z","volume":"27","author":"T Kimata","year":"2012","unstructured":"Kimata T, Kaneko K, Takahashi M, et al. Increased urinary calcium excretion caused by ceftriaxone: possible association with urolithiasis. Pediatr Nephrol. 2012;27:605\u20139.","journal-title":"Pediatr Nephrol"},{"key":"893_CR21","doi-asserted-by":"publisher","first-page":"E186","DOI":"10.1055\/s-0029-1214633","volume":"41","author":"C Palanivelu","year":"2009","unstructured":"Palanivelu C, Jategaonkar P, Rangarajan M, et al. \u201cPseudo\u201d cholelithiasis: sequelae of minimally invasive cholecystectomy with maximum surprise\u2014an unusual case. Endoscopy. 2009;41:E186\u2013187.","journal-title":"Endoscopy"},{"key":"893_CR22","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/j.1651-2227.1999.tb01050.x","volume":"88","author":"F Papadopoulou","year":"1999","unstructured":"Papadopoulou F, Efremidis S, Karyda S, et al. Incidence of ceftriaxone associated gallbladder pseudolithiasis. Acta Paediatr. 1999;88:1352\u20135.","journal-title":"Acta Paediatr"},{"key":"893_CR23","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/ped.12625","volume":"57","author":"S Murata","year":"2015","unstructured":"Murata S, Aomatsu T, Yoden A, et al. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone associated pseudolithiasis. Pediatr Int. 2015;57:942\u20136.","journal-title":"Pediatr Int."},{"key":"893_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4291\/wjgp.v5.i4.405","volume":"5","author":"WY Hung","year":"2014","unstructured":"Hung WY, Lanfranco OA. Contemporary review of drug-induced pancreatitis: a different perspective. World J Gastrointest Pathophysiol. 2014;5:405\u201315.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"893_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1128\/AAC.24.4.529","volume":"24","author":"D Cohen","year":"1983","unstructured":"Cohen D, Appel GB, Scully B, et al. Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis. Antimicrob Agents Chemother. 1983;24:529\u201332.","journal-title":"Antimicrob Agents Chemother"},{"key":"893_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1542\/peds.98.1.133","volume":"98","author":"FM Robertson","year":"1996","unstructured":"Robertson FM, Crombleholme TM, Barlow SE, et al. Ceftriaxone choledocholithiasis. Pediatrics. 1996;98:133\u20135.","journal-title":"Pediatrics"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-019-00893-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11604-019-00893-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-019-00893-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T18:14:46Z","timestamp":1664734486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11604-019-00893-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["893"],"URL":"https:\/\/doi.org\/10.1007\/s11604-019-00893-5","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"23 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the institutional review board of our institution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}